Literature DB >> 16030322

Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography.

Dorothy Guzowski1, Alamelu Chandrasekaran, Craig Gawel, Jacqueline Palma, Jonathan Koenig, Xue Ping Wang, Michael Dosik, Mark Kaplan, Charles C Chu, Sangeeta Chavan, Richard Furie, Emilia Albesiano, Nicholas Chiorazzi, Leslie Goodwin.   

Abstract

Interleukin-10 (IL10), an anti-inflammatory cytokine, has been implicated in a variety of immune- and inflammatory-related diseases. We investigated the following SNPs: -1082, -819, -592 in the promoter region of IL10 in a normal (control) population and selected diseases: breast cancer (BrCa), systemic lupus erythematosus (SLE), and B-cell chronic lymphocytic leukemia (B-CLL) by denaturing high-performance liquid chromatography (DHPLC) and found distinct genotype and haplotype patterns. DHPLC was performed using the Transgenomic WAVE instrument, a mutational discovery tool that allows for high throughout analysis of SNPs. The principle of DHPLC is based on separation of homo- and heteroduplex formation of individual polymerase chain reaction products at specific melting temperatures and set gradients. The melting temperature selected for each SNP was based on size and sequence of the polymerase chain reaction product (for -1082, 57 degrees C; for -819, 58 degrees C; and for -592, 59.2 degrees C). Before fragment mutational analysis, all samples were denatured at 95 degrees C and slowly reannealed to allow for reassociation of different strands. Heteroduplex samples were easily distinguished from homoduplex samples. In order to identify wild type from homozygous mutant, two homoduplex polymerase chain reaction samples had to be mixed together, denatured at 95 degrees C and reannealed. The homozygous mutant, when combined with wild type, displayed a double peak on chromatogram. Once distinct chromatograms were established for each of the SNPs and the nucleotide changes confirmed by sequencing, genotype and haplotype frequencies were tabulated for the groups studied.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16030322      PMCID: PMC2291722     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  70 in total

1.  Single nucleotide polymorphic haplotypes of the interleukin-10 5' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus.

Authors:  E Crawley; P Woo; D A Isenberg
Journal:  Arthritis Rheum       Date:  1999-09

2.  Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21.

Authors:  N Patil; A J Berno; D A Hinds; W A Barrett; J M Doshi; C R Hacker; C R Kautzer; D H Lee; C Marjoribanks; D P McDonough; B T Nguyen; M C Norris; J B Sheehan; N Shen; D Stern; R P Stokowski; D J Thomas; M O Trulson; K R Vyas; K A Frazer; S P Fodor; D R Cox
Journal:  Science       Date:  2001-11-23       Impact factor: 47.728

3.  Haplotype tagging for the identification of common disease genes.

Authors:  G C Johnson; L Esposito; B J Barratt; A N Smith; J Heward; G Di Genova; H Ueda; H J Cordell; I A Eaves; F Dudbridge; R C Twells; F Payne; W Hughes; S Nutland; H Stevens; P Carr; E Tuomilehto-Wolf; J Tuomilehto; S C Gough; D G Clayton; J A Todd
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

4.  High-resolution haplotype structure in the human genome.

Authors:  M J Daly; J D Rioux; S F Schaffner; T J Hudson; E S Lander
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

5.  Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes.

Authors:  S C Hoffmann; E M Stanley; E Darrin Cox; N Craighead; B S DiMercurio; D E Koziol; D M Harlan; A D Kirk; P J Blair
Journal:  Transplantation       Date:  2001-10-27       Impact factor: 4.939

6.  New polymorphisms in the IL-10 promoter region.

Authors:  S D'Alfonso; M Rampi; V Rolando; M Giordano; P Momigliano-Richiardi
Journal:  Genes Immun       Date:  2000-02       Impact factor: 2.676

7.  High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus.

Authors:  M W van der Linden; R G Westendorp; A Sturk; W Bergman; T W Huizinga
Journal:  J Investig Med       Date:  2000-09       Impact factor: 2.895

8.  High-accuracy DNA sequence variation screening by DHPLC.

Authors:  J I Spiegelman; M N Mindrinos; P J Oefner
Journal:  Biotechniques       Date:  2000-11       Impact factor: 1.993

Review 9.  Basic science of HER-2/neu: a review.

Authors:  M C Hung; Y K Lau
Journal:  Semin Oncol       Date:  1999-08       Impact factor: 4.929

Review 10.  The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).

Authors:  Amy M Beebe; Daniel J Cua; Rene de Waal Malefyt
Journal:  Cytokine Growth Factor Rev       Date:  2002 Aug-Oct       Impact factor: 7.638

View more
  18 in total

1.  Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.

Authors:  Zhi-Ming Dai; Ai-Li He; Wang-Gang Zhang; Jie Liu; Xing-Mei Cao; Yin-Xia Chen; Xiao-Rong Ma; Wan-Hong Zhao; Zhi-Jun Dai
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-03-18       Impact factor: 4.575

Review 3.  Association of Interleukin-10 -3575T>A and -1082A>G polymorphisms with non-Hodgkin lymphoma susceptibility: a comprehensive review and meta-analysis.

Authors:  Yan Zhang; Zu-Guang Xia; Jin-Hong Zhu; Min-Bin Chen; Tong-Min Wang; Wen-Xiang Shen; Jing He
Journal:  Mol Genet Genomics       Date:  2015-05-15       Impact factor: 3.291

Review 4.  Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications.

Authors:  Lili Magyari; Dalma Varszegi; Erzsebet Kovesdi; Patricia Sarlos; Bernadett Farago; Andras Javorhazy; Katalin Sumegi; Zsolt Banfai; Bela Melegh
Journal:  World J Orthop       Date:  2014-09-18

5.  Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to Behcet's disease.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

6.  Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2011-05-08       Impact factor: 2.316

7.  Genetic variants in inflammation pathway genes and asthma in glioma susceptibility.

Authors:  E Amirian; Yanhong Liu; Michael E Scheurer; Randa El-Zein; Mark R Gilbert; Melissa L Bondy
Journal:  Neuro Oncol       Date:  2010-02-05       Impact factor: 12.300

Review 8.  Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.

Authors:  Hui Peng; Wei Wang; Mo Zhou; Rui Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2013-05-25       Impact factor: 2.980

9.  Lack of association between the haplotype GCC/ATA polymorphism in the IL-10 promoter and SLE risk: evidence from a meta-analysis.

Authors:  B Wang; Y-G Fan; D-Q Ye
Journal:  Z Rheumatol       Date:  2013-09       Impact factor: 1.372

Review 10.  The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.

Authors:  Zhibin Yu; Qing Liu; Chen Huang; Minghua Wu; Guiyuan Li
Journal:  OMICS       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.